Alnylam Pharmaceuticals (NASDAQ: ALNY) Stock Deep Dive
Read next
Edwards Lifesciences (EW) — From Valve Pioneer to Structural Heart Powerhouse
1. The Premise
Today we are going to be looking at a company whose entire existence is concentrated on solving one disease, in one organ, for one population of patients — and which has spent six decades doing so with such singular intensity that it has become genuinely irreplaceable. Edwards Lifesciences
Intuitive Surgical (ISRG): What Three Years and a New Robot Changed
A Note to Readers
When we first wrote about Intuitive Surgical, the company was the unambiguous, effectively unchallenged leader of a market it had created. The investment thesis was compelling but simple: a dominant installed base, an annuity stream of instruments and service revenue, and a regulatory and switching-cost
Stryker Corporation (SYK): Engineering the Future of Healthcare
1. The Premise: A MedTech Compounder with Two Compounding Engines
The medtech industry is undergoing a structural transformation unlike any in its history. Three forces are converging simultaneously: the most powerful demographic tailwind in recorded medicine — an ageing global population whose joint, cardiovascular, and neurological needs are growing faster than